Antineutrophil cytoplasmic antibodies: appropriate use and interpretation
- PMID: 28043997
- DOI: 10.1136/annrheumdis-2016-210908
Antineutrophil cytoplasmic antibodies: appropriate use and interpretation
Keywords: Autoantibodies; Autoimmunity; Systemic vasculitis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment.Ann Rheum Dis. 2019 Oct;78(10):e113. doi: 10.1136/annrheumdis-2018-214078. Epub 2018 Sep 5. Ann Rheum Dis. 2019. PMID: 30185413 No abstract available.
-
Response to: 'Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment' by Broeders et al.Ann Rheum Dis. 2019 Oct;78(10):e114-e111. doi: 10.1136/annrheumdis-2018-214243. Epub 2018 Sep 5. Ann Rheum Dis. 2019. PMID: 30185416 No abstract available.
Comment on
-
Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.Ann Rheum Dis. 2017 Apr;76(4):647-653. doi: 10.1136/annrheumdis-2016-209507. Epub 2016 Aug 1. Ann Rheum Dis. 2017. PMID: 27481830
-
Testing for antineutrophil cytoplasmic antibodies (ANCAs) in patients with systemic vasculitides and other diseases.Ann Rheum Dis. 2017 Aug;76(8):e23. doi: 10.1136/annrheumdis-2016-210890. Epub 2016 Dec 23. Ann Rheum Dis. 2017. PMID: 28011452 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
